Iterum Therapeutics Plc (ITRM)

$ITRM accumulation?

$ITRM I like that that baby PP at 0.9 is acting as both support and anchor to the share price rn. Still adding. 30% position filled now.

$ITRM Closed up at 1.00. Last few trading days we closed below that important level. Let's never do that again. Baby stepping our way to greatness now...added 177 more today too just because I was bored.

$ITRM hopefully not jinxing it, but there is a reason this is holding above $1. Sure there will be attacks, but this should make you feel good

$ITRM Lol made this profile today just to post bearish. Now that's desperation. 😂

$ITRM keep moving the goal post

$ITRM still no investor slides! This is good!

$ITRM i wonder why he's so upset. lmao. seriously this guy isn't even all that good at hiding his grift. yeah a screenshot proves he's not short. he has to keep "proving" he's not short because he is. his momma told me.

$ITRM So the float could go up 236,088 shares and Itrm roughly gets $500,000 on the balance sheet.

$ITRM AGM pr this week?

$ITRM Attached from ChatGPT is the answer to the warrant question: The June 30, 2025, expiration of certain warrants issued by Iterum Therapeutics (NASDAQ: ITRM) could influence the company's share price, depending on whether these warrants are exercised or allowed to expire. Overview of the June 30, 2025 Warrants In connection with a securities purchase agreement dated June 30, 2020, Iterum issued warrants to purchase up to 236,088 ordinary shares to designees of the placement agent. These warrants have an exercise price of $1.8531 per share and are set to expire on June 30, 2025. As of September 30, 2024, these warrants had not been exercised . Potential Effects on Share Price Warrant Exercise: If holders exercise these warrants, the company would receive additional capital, which could be used for operational purposes. However, the issuance of new shares would increase the total share count, potentially diluting existing shareholders and exerting downward pressure on the share price.

$ITRM SOLMike Is it in Fishman best interest to not make a deal until after June 30 because he will pick up stock options?

$ITRM Whybdont you post your position douche bag, like I posted mine. That’s what I thought

$ITRM In this business, which wholesaler handles your product is a major downstream lever for both commercial launch and M&A. Big pharma acquirers nearly always have established, high-volume contracts with one of the “big three” (AmerisourceBergen, Cardinal Health, McKesson), and locking into a long-term agreement too early can actually limit your flexibility and negotiating leverage. Iterum is keeping that card close for a reason. If a buyout is in play, the buyer will want to use their own distributor relationships for pricing power, logistics, and rebate management. By holding off on a distributor contract, Fishman avoids creating friction for a potential acquirer—there’s no legacy deal to unwind, no termination penalties, and no lost synergy. This is a playbook move learned from deals like Durata, where the company’s distributor choice and time in-market mattered for integration. Fishman’s approach signals to any potential acquirer that Iterum is “plug and play”—ready for immediate integration without the operational headaches that come from mismatched third-party contracts. So yes, the distributor is still “to be determined” by design. It keeps all options open for M&A and ensures a smoother transition if/when a deal goes through. That’s how you maximize both speed and value in a sale.

$ATPC $ATCH $ITRM $MIST $XLO

$ITRM Fishman on the call, clearly mentioned they haven’t finalized the distributor. Given how critical the big 3 distributors are in the field and the implied contracts, was this strategic? Did they learn from Durata which had already been in distribution for a few months before acquisition? All the big BPs have their preferred wholesaler…

$ITRM which is worse ? A) spambots like troy (probably switched to @DallasInvestors ) targeting the lower 5% to leave with horribly dorky memes. B) the "i swear i'm just being balanced" shorts like @Keepitmoving , scaring off the retail investor shopping around and just starting to do their DD the lower 5% will shake out anyway. we're better off without them. troy is doing us a favor. now the ones just starting to do their DD can be longs who add volume and value without bolting and triggering panic because they know what they're holding. but if they just read about 150M shelf without digging.. well.. i'd flip the page to the next one if i'm just speed reading for my next trade. i know it's just all part of the game but this ticker needs more attention and these fake bulls are doing all they can to prevent it. they're not balanced they're just coolers (creepy dudes sent by casinos to cool off a gambler on a winning streak. check out the movie "the cooler" 2003)

$ITRM Bamboo Shoot Metaphor for Investing: When you plant a bamboo seed, it spends years developing a deep root system and underground network before any shoots appear above ground. But once it’s ready, the bamboo grows rapidly and visibly. This illustrates how meaningful results often require a long period of unseen preparation and effort. Similarly, in investing, there is no instant gratification — patience and long-term commitment are essential. I saw this today and thought it fits here perfect.

$ITRM North Jersey 18 applicants Philly 19 applicants Fort Worth 23 applicants Austin/San Antoino 22 applicants Tampa 48 applicants West Palm Beach 8 applicants Dallas 16 applicants Miami 31 applicants North Florida 21 applicants Plano 20 applicants South Atlanta 17 applicants Central New Jersey 20 applicants Manhattan 25 applicants Orlando 16 applicants North Atlanta 11 applicants North Houston 27 applicants Brooklyn/Queens 9 applicants Yonkers 6 applicants South Houston 12 applicants Nassau Cty/Long Island 10 applicants Stay Tuned as we buildout, Same Bat time, Same Bat channel

$ITRM Job postings Itrm/Eversana https://www.linkedin.com/jobs/search/?currentJobId=4248936094&keywords=eversana%20pharmaceutical%20sales%20representative

$ITRM 💯